The pharmaceutical and health products industry has long been the top dog on K Street. Since 1998, the industry has spent more than $1.6 billion on federal lobbying. Last year alone, it spent more than $234 million — a sum that translates into roughly $125,000 every hour that Congress was actually in session.
Read more:
http://globalbestpractice.blogspot.com/2009/07/big-pharma-big-lobby-big-money.html
Tags: Obama, K Street, PHRMA, Medicare, Medicaid, the State Children's Health Insurance Program, SCHIP, Medicare Part D, FDA, Vioxx, Hatch-Waxman Act, Greater Access to Affordable Pharmaceuticals Act, Global Best Practice,
No comments:
Post a Comment